 |
 |
| 序号 | 股票 | 持股数量(股) | 持股变动 | 占总股本比例 | 报告期 | |
| 1 | 昭衍新药 | 249615 | 减持 | 0.999 | 0.0334% | 2026-09-30 |
| 2 | 昭衍新药 | 252815 | 增持 | 0.999 | 0.0337% | 2026-06-30 |
| 3 | 昭衍新药 | 225015 | 增持 | 0.999 | 0.0300% | 2026-03-31 |
| 4 | 昭衍新药 | 171015 | 减持 | 0.999 | 0.0228% | 2025-12-31 |
| 5 | 昭衍新药 | 184215 | 增持 | 0.999 | 0.0246% | 2025-09-30 |
| 6 | 昭衍新药 | 100700 | 增持 | 0.999 | 0.0134% | 2025-06-30 |
| 7 | 昭衍新药 | 87000 | 减持 | 0.999 | 0.0116% | 2024-12-31 |
| 8 | 昭衍新药 | 91200 | 减持 | 0.999 | 0.0122% | 2024-06-30 |
| 9 | 昭衍新药 | 105500 | 增持 | 0.999 | 0.0141% | 2023-12-31 |
|
|